AI
Insilico Medicine signs a $2.5 billion AI drug discovery deal with SK Biopharmaceuticals for neuroimmune disorders
POSTS FROM
News
AI
Insilico Medicine signs a $2.5 billion AI drug discovery deal with SK Biopharmaceuticals for neuroimmune disorders
AI
Oracle cut 21,000 jobs to fund its $50 billion AI buildout and workers say they trained their own replacements
AI
Qualcomm is buying Modular for $4 billion to take on Nvidia where it actually counts
AI
SpaceX enters the bond market with $20 billion in debt and a balance sheet that reads like a sovereign wealth fund
AI
Chevron and Microsoft sign a 20-year gas deal that turns an oil major into an AI infrastructure company
AI
Five Eyes agencies warn that AI-powered cyberattacks are months away as the US moves to lock down frontier models
AI
SpaceX lands a $6.3 billion computing deal with Reflection AI and is quietly becoming the infrastructure backbone of frontier AI
AI
Meta buys into CRED and bets its WhatsApp future on an Indian founder
BUSINESS
The New York Stock Exchange owner is betting that tokenized finance needs a political fixer as much as it needs a tech stack
